anon's dig: Adm Rogers securing the Pfizer vaxx supplies
U.S. Navy Admiral (Ret.) Michael S. Rogers named to Claroty Advisory Board
Feb. 13, 2019
As Chairman of Claroty’s Board of Advisors, Rogers will lead a distinguished cadre of business and security leaders
NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) – Claroty, the leader in operational technology (OT) security, has announced the appointment of U.S. Navy Admiral (Ret.) Michael S. Rogers as Chairman of the company’s Board of Advisors, effective immediately.
Admiral Rogers recently retired from the United States Navy after a distinguished 37-year career. In 2014, Rogers was appointed by President Barack Obama as the 17th Director of the National Security Agency and the 2nd Commander of the U.S. Cyber Command, receiving unanimous confirmation from the United States Senate.
“It’s both humbling and a great source of pride that Admiral Rogers chose to join our mission of protecting industrial networks from the most sophisticated cyber threats,” said Amir Zilberstein, Co-founder and CEO of Claroty. “His combination of operational experience, executive management and leadership in the cybersecurity field is unrivaled, and he will be a tremendous asset to both our team and our customers.”
https://www.securityinfowatch.com/security-executives/press-release/21068445/claroty-appoints-former-head-of-nsa-and-us-cyber-command-to-lead-advisory-board-us-navy-admiral-ret-michael-s-rogers-named-to-claroty-advisory-board
Last week, Pfizer Head of Global Automation Engineering Jim LaBonty sat down with Claroty SVP of Global Customer Care Guilad Regev to share insight into Pfizer’s industrial cybersecurity journey, securing COVID vaccine production while meeting unprecedented demand, and more. Edited for brevity and clarity, this blog shares some highlights from their conversation.
Q: What led to Pfizer’s decision to adopt an operational technology (OT)-focused solution to secure your manufacturing sites?
In the biopharma arena, our wake-up call really happened in 2017, when [Pfizer competitor] Merck MSD was majorly impacted by NotPetya, affecting its manufacturing capability and supply chain across the globe. That was the turning point for Pfizer to really start thinking about the potential impact of a cyber attack on our operations. By the end of 2017, our board had issued a strong directive to better secure our production floor systems at manufacturing sites.
https://www.claroty.com/?s=Pfizer
https://www.claroty.com/2021/04/28/blog-industrial-cybersecurity-journey-with-pfizer/
https://youtu.be/Xr2caaJaluk